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The matrix (M1) protein of influenza A virus is a multifunctional protein that plays essential
structural and functional roles in the virus life cycle. It drives virus budding and is the major protein
component of the virion, where it forms an intermediate layer between the viral envelope and
integral membrane proteins and the genomic ribonucleoproteins (RNPs). It also helps to control
the intracellular trafficking of RNPs. These roles are mediated primarily via protein–protein
interactions with viral and possibly cellular proteins. Here, the regions of M1 involved in binding
the viral RNPs and in mediating homo-oligomerization are identified. In vitro, by using recombinant
proteins, it was found that the middle domain of M1 was responsible for binding NP and that this
interaction did not require RNA. Similarly, only M1 polypeptides containing the middle domain
were able to bind to RNP–M1 complexes isolated from purified virus. When M1 self-association
was examined, all three domains of the protein participated in homo-oligomerization although,
again, the middle domain was dominant and self-associated efficiently in the absence of the
N- and C-terminal domains. However, when the individual fragments of M1 were tagged with
green fluorescent protein and expressed in virus-infected cells, microscopy of filamentous
particles showed that only full-length M1 was incorporated into budding virions. It is concluded
that the middle domain of M1 is primarily responsible for binding NP and self-association, but
that additional interactions are required for efficient incorporation of M1 into virus particles.
INTRODUCTION
The influenza A virus matrix protein M1 is a multi-
functional protein playing many essential roles throughout
the virus life cycle. M1 forms the major structural com-
ponent of the virion, lying beneath a lipid envelope con-
taining the viral haemagglutinin (HA) and neuraminidase
(NA) glycoproteins and the M2 ion channel (Nayak et al.,
2004). M1 in turn surrounds the genomic ribonucleo-
proteins (RNPs). RNPs consist of the viral RNA poly-
merase and a chain of nucleoprotein (NP) monomers,
around which the negative-sense RNA segments are
wrapped (Portela & Digard, 2002). M1 is also complexed
with small quantities of the viral nuclear export protein
(NEP/NS2) in the virion (Yasuda et al., 1993). As well as
being the most abundant polypeptide in virions, M1 drives
virus budding. Expression of M1 alone in cells produces
virus-like particles (Gomez-Puertas et al., 2000; Latham &
Galarza, 2001), whilst in the context of authentic virus, M1
amino acid sequence polymorphisms control particle shape
(Bourmakina & Garcia-Sastre, 2003; Elleman & Barclay,
2004). Vesicular budding of M1 in the absence of other viral
proteins reflects its ability to bind lipid membranes
(Gregoriades, 1980), although, in infected cells, inter-
actions with the cytoplasmic tails of the viral membrane
proteins may also be important (Enami & Enami, 1996; Ali
et al., 2000; Zhang et al., 2000). Budding presumably also
depends on the ability of M1 to oligomerize (Sha & Luo,
1997; Zhao et al., 1998; Ruigrok et al., 2000).
M1 also controls the intracellular trafficking of RNPs.
During entry of the virus, the M1–RNP interaction must be
disrupted to enable transport of RNPs into the nucleus
(Martin & Helenius, 1991b; Bui et al., 1996). M1 also
regulates RNP nuclear export (Martin & Helenius, 1991a;
Bui et al., 2000). Following the ‘late’ synthesis of M1, some
enters the nucleus (Bucher et al., 1989) and interacts with
RNPs. Following this, NEP binds to M1 to form a ‘daisy
chain’ of proteins (Yasuda et al., 1993; Akarsu et al., 2003).
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protein CRM1 (O’Neill et al., 1998; Neumann et al., 2000;
Elton et al., 2001), which mediates RNP export.
The M1 polypeptide possesses N-terminal (N), linker (L),
middle (M) and C-terminal (C) domains (Fig. 1a). The N,
L and M sequences have been analysed by X-ray diffraction
(Sha & Luo, 1997; Harris et al., 2001; Arzt et al., 2004).
These studies show that the N and M domains are a-helical
bundles linked by a short helix (L domain). Circular di-
chroism spectroscopy suggests that the C-terminal domain
also has an a-helical structure (Arzt et al., 2001). The M
and C domains are separated by a zinc finger-like motif
that is thought to act as an interdomain linker (Wakefield
& Brownlee, 1989; Elster et al., 1994; Arzt et al., 2001).
Thus, M1 plays key roles in controlling RNP trafficking
and virion assembly through a web of protein–protein
interactions. Currently, there is controversy over which
domain(s) of M1 interacts with RNPs. Ye et al. (1999)
concluded that the N-terminal domain of M1 mediates
a protein–protein contact with NP, whilst a basic RNA-
binding motif,
101RKLKR
105 (Wakefield & Brownlee, 1989;
Watanabe et al., 1996; Elster et al., 1997), located in the
middle domain, interacts with the viral RNA (vRNA). In
diametric contrast, Baudin et al. (2001) found that the
C-terminal domain of M1 bound to RNPs or NP alone, but
that the N+M domains did not. Due to these unresolved
discrepancies, mutational studies of M1 using reverse
genetics to test hypotheses of how the protein functions
cannot be interpreted fully.
The aim of this paper was to identify the domains of M1
that are necessary for interacting with RNPs and/or NP, for
oligomerization and for incorporation into virus particles.
The middle domain of M1 was found to play an important
role in both oligomerization and RNP–NP interactions.
However, only full-length M1 was incorporated into bud-
ding viral particles, suggesting that additional interactions
other than self-association and RNP binding are necessary
for virion assembly.
METHODS
Cells and viruses. Madin–Darby canine kidney (MDCK) cells were
cultured as described previously (Carrasco et al., 2004). A filamentous
variant (PR8/MUd) of virus strain A/PR/8/34 (PR8) was created by
reverse genetics using the PR8 clones described by de Wit et al.
(2004), except for segment 7, which was from A/Udorn/72 (Elleman
& Barclay, 2004). For biochemical analyses, egg-grown virus (a vaccine
strain reassortant between PR8 and A/Johannesburg/33/94) was
gradient-purified as described previously (Blok et al., 1996).
Plasmids. Plasmids expressing PR8 NP fused to glutathionine
S-transferase (GST) or maltose-binding protein (MBP) have been
described previously (Digard et al., 1999). Plasmid pGFPM703 that
expresses full-length PR8 M1 fused to green fluorescent protein (GFP)
was described by Simpson-Holley et al. (2002). To construct plasmids
expressing the various domains of M1, regions of the gene were PCR-
amplified from a cDNA clone of PR8 M1 (Young et al., 1983)
and cloned into either pGEX-3X (Pharmacia; for expression as
GST-fusion proteins), pEGFP-c2 (Clontech; for expression as GFP-
fusion proteins) or pKT-0 (Blok et al., 1996; for in vitro expression
of untagged protein from a T7 RNA polymerase promoter). PCR
primers were designed by using the domain boundaries assigned by
Fig. 1. Domain structure and NP-binding activity of M1. (a)
Schematic diagram of the domain structure of M1 as defined by
crystallography (coordinates are amino acid number) and the
subdivisions used in this study. Also shown is the location of the
RKLKR motif important in binding RNA and NEP. (b–d) NP-
binding activity of GST, the indicated GST–M1 fusion proteins or
GST–NP (NP). [
35S]Methionine-radiolabelled, in vitro-translated
NP (b, c) or purified NP (d) was incubated with 6 mg of each fusion
protein attached to glutathione–Sepharose beads and bound
material was analysed by SDS-PAGE and (b) Coomassie blue
staining (to visualize the input GST-fusion proteins), (c) auto-
radiography or (d) Western blot analysis with anti-NP. Aliquots
equivalent to one-quarter of the input soluble NP (1/4 Total) were
also analysed to provide a guide to binding efficiency. Molecular
mass markers are indicated on the left and the position of specified
proteins on the right. The approximately 43 kDa radiolabelled
species visible in (c) is an aberrant NP in vitro translation product.
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http://vir.sgmjournals.org 2281Sha & Luo (1997) (Fig. 1a). Forward primers included a common
BglII restriction site and an ATG codon (59-CTCAGATCTCGATG),
whilst reverse primers included a downstream sequence (59-CGAAT-
TCTCA) with an EcoRI site for subcloning purposes and a stop
codon. The unique sequences used were 59-AGTCTTCTAACC
(forward primer to amplify from codon 1 onwards), 59-GGGGATC-
CAAATAAC (to amplify from codon 88 onwards), 59-GTGACAA-
CAACC (to amplify from codon 165 onwards), 59-GAGCGTGA-
ACACAAA (reverse primer to amplify backwards from codon 67),
59-GTTCCCATTAAGGGC (to amplify backwards from codon 88),
59-TTGCCTATGAGACCG (to amplify backwards from codon 165)
and 59-CTTGAACCGTTG (to amplify backwards from codon 252).
Pairs of forward and reverse primers were used to amplify full-length
M1, N, N+L, N+M, M, M+C and C domain sequences to clone
into pGEX-3X, and full-length M1, N+M, M, M+C and C domain
sequences to clone into pEGFP-c2. N and N+L domain GFP and
pKT constructs were made by digesting pGFPM703 with PstIo r
BamHI to truncate the M1 ORF at codons 75 and 90, respectively.
Antibodies. Antisera against NP (2915) were raised by immunizing
rabbits with MBP–NP. Antisera against PR8 virus were described
previously (Amorim et al., 2006). Anti-GFP antibody JL8 was
obtained from Clontech. Horseradish peroxidase-conjugated anti-
bodies for Western blot analysis were obtained from GE Healthcare.
For immunofluorescence microscopy, anti-rabbit IgG conjugated to
Alexa 594 (Molecular Probes) was used.
Protein expression and purification. GST-tagged M1, NP and
MBP–NP fusion proteins were expressed in Escherichia coli TG1 cells
and purified by affinity chromatography on glutathione–Sepharose
(GE Healthcare) or amylose resin (New England Biolabs), respectively
(Digard et al., 1999). A salt wash (1 M NaCl for GST- and 2 M NaCl
for MBP-fusion constructs) was included to remove co-purifying
bacterial RNA (Wakefield & Brownlee, 1989; Digard et al., 1999).
Purified NP was obtained by removal of the MBP moiety from the
MBP–NP fusion protein (Elton et al., 1999b). NP and M1 proteins
were radiolabelled with [
35S]methionine in rabbit reticulocyte lysate
(Promega) by using a coupled in vitro transcription–translation
system (Craig et al., 1992).
Protein-binding assays. One microlitre of in vitro-translated
protein or 0.3 mg purified NP protein was mixed with 100 mlI P
buffer [100 mM KCl, 50 mM Tris/Cl (pH 7.6), 5 mM MgCl2,1m M
dithiothreitol (DTT), 0.1% Nonidet P-40] and incubated with 6 mg
(unless otherwise stated) GST-fusion protein attached to 40 ml
glutathione–Sepharose beads. The reaction was incubated for 1 h at
room temperature and then centrifuged to collect the solid phase. The
pellet was washed three times with 750 ml IP buffer and bound
proteins were eluted by boiling in SDS-PAGE sample buffer. Samples
were separated by SDS-PAGE and analysed by staining with
Coomassie brilliant blue dye and autoradiography, or by Western
blot (Elton et al., 1999a).
RNP co-sedimentation assay. Purified virus (approx. 15 mg) was
lysed by dilution into 17.5 ml band-shift buffer [20 mM Tris/Cl
(pH 7.6), 50 mM NaCl, 5 mM MgCl2, 0.5 mM DTT] containing
0.5% Nonidet P-40 and incubated with 2.5 ml in vitro translation
mixture. The reactions were layered on top of 100 ml 20% sucrose in
band-shift buffer and centrifuged at 120000 gav for 15 min at 4 uCi n
a Beckman benchtop ultracentrifuge using a TLA 100 rotor, to
separate viral lipid and other low-density material from virion cores
containing M1 and RNPs. Pellet and supernatant fractions were
analysed by SDS-PAGE, Coomassie staining and autoradiography.
Transfection and infection of cells. MDCK cells (4610
5 per well)
were transfected in suspension with 0.8 mg plasmid by using Lipofect-
amine (Invitrogen) according to the manufacturer’s instructions and
seeded into 24-well plates. After 24 h, cells were superinfected with
PR8/MUd virus at an m.o.i. of 5. Twelve hours later, cells were fixed
in PBS containing 4% formaldehyde and stained for surface HA and
NA with anti-PR8 serum as described previously (Simpson-Holley
et al., 2002). Fluorescent emissions were imaged by using a Leica
TCS-NT confocal microscope (Simpson-Holley et al., 2002).
RESULTS
Identification of M1 domains involved in NP
binding
Our aim was to map the M1 amino acid sequences
responsible for NP binding through deletion mutagenesis
of M1. Many earlier studies mapping the interaction of M1
with RNPs employed the strategy of using either con-
venient restriction-enzyme sites to construct gene deletions
(Watanabe et al., 1996; Ye et al., 1999) or chemical treat-
ment of the protein (Ye et al., 1987, 1989) to create M1
fragments. However, with the currently available high-
resolution structural information, it was possible to design
a set of M1 deletion mutants that corresponded to the
domain structure of the polypeptide as revealed by X-ray
crystallography, circular dichroism spectroscopy and
structure-prediction algorithms (Sha & Luo, 1997; Arzt
et al., 2001; Harris et al., 2001). Accordingly, a set of
mutants corresponding to the N, L, M and C domains
were created as gene fusions with the C terminus of GST
(Fig. 1a). A plasmid encoding full-length M1 (WT) fused
to GST was also created. All seven fusion proteins were
successfully expressed and purified from E. coli as reason-
ably homogeneous preparations (Fig. 1b, lanes 3–9).
PR8 NP was radiolabelled with [
35S]methionine by in vitro
transcription–translation and tested for its ability to bind
the GST–M1 fusion proteins, GST alone (as a negative
control) or GST–NP (as a positive control) in pull-down
assays. From the Coomassie-stained gel (Fig. 1b), it could
be seen that approximately equal amounts of the fusion
proteins were added to each binding reaction. Autoradio-
graphy revealed that, as expected (Elton et al., 1999a), only
trace amounts of NP bound to GST alone (Fig. 1c, lane 10),
but large quantities bound to GST–NP (lane 2). In com-
parison to GST–NP, full-length GST–M1 bound less NP,
but still well above background levels (compare lanes 3
and 10). The M1 N, N+L or C domains displayed only
background amounts of NP binding (lanes 4, 5 and 9). In
contrast, fusion proteins containing the middle domain
(N+M, M and M+C) displayed NP-binding activity
similar to that of the full-length GST–M1 fusion protein
(lanes 6–8). Replicate experiments were performed and
quantified by densitometry. Results confirmed that the N,
N+L and C domains bound amounts of NP that were
only slightly above background (Fig. 2a). In contrast,
any fusion protein containing the M domain possessed
substantial binding ability, with the M domain alone
approaching that observed for the full-length protein
(Fig. 2a).
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further by titrating a constant amount of NP with a range
of GST fusion-protein concentrations. As before, the N,
N+L and C domains bound only small amounts of NP,
even with increasing concentrations of fusion protein
(Fig. 2b). However, fusion proteins containing the M
domain displayed much higher levels of NP-binding
activity that titrated with increasing concentrations of
ligand before reaching a plateau. Full-length M1–GST also
exhibited titratable NP binding but, unlike the separate
domains, NP binding at higher concentrations decreased
reproducibly, rather than reaching a constant maximum.
To confirm further that the middle domain of M1 interacts
with NP, the protein-binding assay was repeated ‘in
reverse’. Untagged WT radiolabelled M1, the M1 deletion
mutants and NP were in vitro-translated in rabbit
reticulocyte lysate and tested for their ability to bind either
GST–NP or GST alone.
Only trace amounts of radiolabelled NP bound to GST
(Fig. 3, lane 3) and strong self-association was observed
(lane 2). Full-length M1, N+M, M and M+C domains
also bound to GST–NP (lanes 5, 14, 17 and 20) and
exhibited only background binding to GST (lanes 6, 15, 18
and 21). No detectable binding to NP was seen with the N,
N+L or C domains (lanes 7–12, 22–24). These results
support the finding that the middle domain of M1
mediates binding to NP.
Role of RNP organization in M1 binding
Previous studies examining M1–RNP interactions that
utilized authentic RNPs as the binding target suggested that
M1 binds via both M1–NP and M1–RNA interactions
(Elster et al., 1997; Perez & Donis, 1998; Ye et al., 1999).
The experimental system that we used above does not
contain genuine RNPs, because neither vRNA nor the viral
polymerase are present. However, the in vitro transcrip-
tion–translation system generates large quantities of single-
stranded RNA and, because NP binds RNA without
apparent sequence specificity (Portela & Digard, 2002), it
is possible that NP–RNA complexes were formed that
might behave similarly to RNPs. It is also relevant that the
M domain of M1 contains an RNA-binding motif (Ye
et al., 1989; Watanabe et al., 1996; Elster et al., 1997).
Accordingly, to investigate further whether NP–RNA
complexes were involved in M1 interactions in our system,
we used purified NP protein in which salt washes during
affinity purification, followed by heparin–agarose chroma-
tography, ensured that the protein was free of RNA (Elton
et al., 1999b). Purified NP bound well to GST–NP, but only
background amounts bound to GST (Fig. 1d). The GST-
fusion proteins containing the N, N+L and C domains of
M1 displayed poor affinity for the purified NP but, again,
strong binding was observed with N+M, M and M+C
fusion proteins. Overall, there was no significant difference
in behaviour between binding assays using radiolabelled
NP in a complex cell extract and those using purified NP
with regards to the relative binding activities of the M1
domains. Furthermore, identical results were obtained with
an NP RNA-binding mutant (S314N; Medcalf et al., 1999),
and RNase treatment of the rabbit reticulocyte lysates did
not alter the pattern of binding specificities (data not
shown). Thus, both binding assays examine predominantly
M1–NP interactions and these are mediated primarily by
the M domain of M1.
Interactions between M1 and non-RNP NP are not neces-
sarily the same as interactions between M1 and RNPs.
Accordingly, we tested binding of radiolabelled M1 frag-
ments to authentic RNPs. RNPs were obtained by lysing
Fig. 2. Quantitative analysis of NP- and M1-binding activity of the
GST–M1 fusion proteins. (a) The amount of bound radiolabelled
NP or M1 from three independent assays with the indicated GST-
fusion proteins was quantified by densitometry. Values were
corrected by the subtraction of any background seen with GST
only, normalized with respect to the amount bound by WT M1, and
plotted as the mean±SD. (b) The amount of radiolabelled NP
bound by increasing concentrations of the indicated GST-fusion
proteins was quantified similarly and expressed as the percentage
of input material bound. Values are from a single representative
experiment, except for full-length GST–M1, where the mean±
range of three experiments is plotted.
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with in vitro-translated WT and deletion-mutant M1
polypeptides. After centrifugation through a 20% sucrose
cushion to separate virion cores (comprising RNPs and
associated M1) from lipid and other low-density material,
the pellet and supernatant fractions were collected and
analysed by SDS-PAGE. Coomassie blue staining revealed
rabbit globin and ribosomal and viral envelope proteins to
be in the supernatant fraction, whereas NP and M1 were in
the pellet, representing virion cores (Fig. 4a). Autoradio-
grams showed that exogenous, full-length M1 partitioned
mainly to the supernatant in the absence of lysed virus,
whereas in the presence of purified virus, most of the
radiolabelled M1 was found in the pellet, indicating that it
interacted with the virion cores (Fig. 4b, lanes 1–5). A
similar pattern was also observed with the N+M deletion
mutant (lanes 16–20). The middle domain of M1 and the
M+C fragment also displayed substantial levels of binding
to virion cores (lanes 21–30), but the majority of the N,
N+L and C fragments remained in the supernatant, even
in the presence of virion cores (lanes 6–15, 31–36). Quanti-
fication of replicate experiments confirmed that substantial
amounts of M1 polypeptides containing the middle domain
co-pelleted with RNPs, whilst the N and N+L domains
bound poorly and the C-terminal domain at background
levels (Fig. 4c). Thus, consistent with previous assays, the
middle domain of M1 mediates binding to authentic virion
cores.
M1 oligomerization
During viral assembly, M1 is thought to drive budding at
the cell surface through its ability to interact with the
plasma membrane and to oligomerize (Sha & Luo, 1997;
Zhao et al., 1998; Gomez-Puertas et al., 2000; Ruigrok et al.,
2000). Indeed, the virion core-binding assay (Fig. 4) could
potentially reflect M1–M1 interactions as well as RNP
binding. Accordingly, to gain a better understanding of
the mechanism of M1–M1 polymerization, the GST–M1
fusion constructs were tested for their ability to interact
with in vitro-translated M1 polypeptides. WT radiolabelled
M1 bound to full-length GST–M1, but not to GST alone
(Fig. 5a, lanes 2 and 9), indicating self-association in the
absence of a membrane surface. Self-association of full-
length M1 was also seen with all the GST–M1 sub-
fragments (Fig. 5a, lanes 3–8). In replicate experiments, the
N, N+L and N+M domain constructs bound similar
amounts of in vitro-translated M1 to the full-length GST–
M1 fusion protein, whereas the C-terminal domain had
around 40% of WT-binding activity (Fig. 2a). For the N,
N+L and C fragments, this contrasts with their almost
total lack of NP-binding activity (Fig. 2a). The M and
M+C proteins showed the strongest affinity for WT M1
(Fig. 5a, lanes 6 and 7), with on average twice the binding
activity of the full-length GST-fusion protein (Fig. 2a).
Crystal structures of the N+M domains suggest that they
dimerize through M–M domain contacts at both neutral
and acidic pH, with additional N–N domain interactions at
neutral pH (Sha & Luo, 1997; Arzt et al., 2001; Harris et al.,
2001). To test whether these interactions occur in solution,
we next examined binding of individual M1 domains to the
panel of GST–M1 fusion proteins. In confirmation of the
intersubunit interactions seen in both neutral- and acidic-
pH structures, the M domain self-associated strongly (Fig.
5c, lane 6). It also bound well to the N+M, M+C and full-
length GST-fusion proteins, but weakly to the N and N+L
and C domain constructs (Fig. 5c). The isolated N domain
did not interact strongly with any of the GST–M1 fusion
constructs, but bound best to the full-length protein and to
the M and M+C peptides (Fig. 5b). No detectable self-
interactions were seen between N domains, and only very
weak binding occurred to the N+L protein (Fig. 5b, lanes
Fig. 3. Ability of in vitro-translated M1-domain
fragments to bind to GST–NP. Aliquots of the
indicated radiolabelled polypeptides were
analysed by SDS-PAGE and autoradiography
before (T) or after binding to GST–NP (N) or
GST (G). Molecular mass markers are indi-
cated on the left; arrows indicate the expected
protein sizes for M+C and C sub-fragments.
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vitro-translated N+L polypeptide was used as the target
(data not shown). The C domain bound reasonably well to
full-length GST–M1 (Fig. 5d, lane 9) and weakly to the M
and N+M ligands (lanes 5 and 6). Overall, we conclude
that the M domain of M1 is the main determinant of self-
association, but that the N- and C-terminal domains make
significant contributions.
As the same domain of M1 plays roles in binding NP and
oligomerization, the question arises as to whether the
interactions are competitive. To test this, we examined the
ability of the M1 middle domain to bind full-length
radiolabelled M1 in the presence of increasing amounts of
purified NP. As before, WT M1 bound strongly to the
immobilized GST–middle domain fusion protein, but not
to GST alone (Fig. 6a, lanes 2 and 7). However, this was not
altered significantly by the addition of up to a fivefold
molar excess (with respect to the GST polypeptides) of
NP (lanes 3–6, 8–11). When replicate experiments were
quantified, M1 self-association was seen to be independent
of NP concentration (Fig. 6b). Thus, NP does not interfere
with M1 self-association.
Domain requirements for incorporation of M1 into
virions
Based on the observation that the middle domain of M1
mediates an interaction with both RNPs and itself, we
tested whether this was sufficient for M1 incorporation
into budding viral particles. For this, we took advantage of
the fact that certain strains of influenza A virus produce
micrometre-length filamentous particles and of our pre-
vious demonstration that incorporation of full-length M1
fused to GFP into these virions is visualized readily by
fluorescence microscopy (Simpson-Holley et al., 2002).
Accordingly, a set of plasmids encoding the various
domains of M1 fused to the C terminus of GFP were
transfected into MDCK cells. Following overnight incuba-
tion, Western blot analysis of cell lysates using anti-GFP
serum confirmed that all five sub-fragments of M1, along
with GFP itself and the WT GFP–M1 fusion protein,
expressed polypeptides of the expected size (Fig. 7).
Another set of transfected cells was superinfected with
the filamentous PR8/MUd virus. At 12 h post-infection,
cells were fixed and the cell surfaces were stained for viral
glycoproteins and analysed by confocal microscopy. This
Fig. 4. Virion RNP core co-sedimentation assay. Aliquots of the indicated radiolabelled, in vitro-translated M1 polypeptides
were incubated in the presence (+) or absence (”) of detergent-disrupted virus and analysed by SDS-PAGE and (a)
Coomassie blue staining or (b) autoradiography before (T) or after separation into pellet (P) and supernatant (S) fractions by
centrifugation. (a) Molecular mass markers are indicated on the left and the position of specified proteins on the right. (c) The
percentage of M1 polypeptides in the pellet fraction was quantified by densitometry. The mean±range of two or three
independent experiments is plotted.
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the surface of the infected cells (Fig. 8), but not mock-
infected cells (data not shown). When infected cells were
imaged in the z-axis, the filaments were visualized clearly as
structures exceeding 10 mm in length projecting from the
apical surfaces of the cells (Fig. 8, lower panels). In cells
expressing WT M1 fused to GFP, obvious green, filamen-
tous structures were formed that co-localized with the anti-
PR8 staining (Fig. 8a), indicating efficient packaging of this
fusion protein into virus particles. As observed previously
(Simpson-Holley et al., 2002), similar packaging of GFP
alone was not seen (Fig. 8b). However, no significant incor-
poration of any of the M1 deletion mutants was observed,
despite a proportion of each protein being resident in both
the nucleus and cytoplasm and thus at least potentially
available for interactions with RNPs and/or the plasma
membrane (Fig. 8c–g). Therefore, although the M domain of
M1mediatesefficientbinding toNPand self-association,itis
not sufficient for incorporation into virus particles, suggest-
ing that additional interactions are necessary.
DISCUSSION
Previous studies mapping the regions of M1 responsible for
binding RNPs have given contradictory results. Ye et al.
(1999) concluded that the association involves aa 1–135
of M1, encompassing the N-terminal domain, and helices
6–8 of the middle domain, and found no activity from
C-terminal fragments of M1. In contrast, Baudin et al.
(2001) concluded the C-terminal domain of M1 mediated
the RNP–NP association, but saw no activity from the
N+M domain. The involvement of vRNA in the M1–RNP
interaction has also proved contentious, with one study
finding it essential (Melnikov et al., 1985), another (Ye
et al., 1999) a contributory factor, whereas Baudin et al.
Fig. 5. Self-association of M1. Aliquots of the indicated radio-
labelled, in vitro-translated M1 polypeptides were analysed by
SDS-PAGE and autoradiography before (T) or after binding to a
panel of GST–M1 fusion proteins.
Fig. 6. Effect of excess NP on M1 self-association. (a) Aliquots of
radiolabelled, in vitro-translated WT M1 were analysed by SDS-
PAGE and autoradiography before (T) or after binding to GST–
middle domain (GST–Mid) or GST in the presence of the indicated
amounts of NP. (b) Bound M1 was quantified by densitometry and
plotted (mean±range of two independent experiments) relative to
the amount bound in the absence of NP.
Fig. 7. Expression of GFP–M1 fusion proteins in MDCK cells.
Lysates from cells transfected (or mock-transfected) with plasmids
expressing the indicated GFP-fusion proteins were separated by
SDS-PAGE and analysed by Western blot with anti-GFP serum.
Molecular mass markers are indicated on the left.
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required for an M1–NP interaction, but cannot rule it out
as a contributory factor. Regarding the domains of M1
involved in binding RNPs, our results are in broad agree-
ment with the findings of Ye et al. (1999), in that we find
activity from the N+M domains, but conflict with those of
Baudin et al. (2001). Our results are also consistent with
reverse-genetics studies showing that mutation of arginine
residues in the basic stretch of the middle domain weakened
M1–RNP interactions and reduced virus viability (Liu &
Ye, 2004). The reasons for the discrepancies regarding the
NP-binding activity of the M1 C-terminal domain are not
clear. Ye et al. (1999) studied A/WSN/33 virus, whereas
we and Baudin et al. (2001) used PR8, so strain-specific
differences seem an unlikely explanation. Ye et al. (1999)
expressed M1 fragments in rabbit reticulocyte lysate,
whereas Baudin et al. (2001) used E. coli. Here, we used
both approaches with identical results, so the choice of
expression systems does not explain the discrepancies. We
have not examined the folding of the proteins used here
directly, but their ready expression in a variety of systems
and evident activity in oligomerization are not consistent
with global misfolding.
Crystallographic packing of N+M domain monomers
suggests the possibility that M1 oligomerization occurs
via homopolymeric interactions between the M and N
domains (Sha & Luo, 1997; Arzt et al., 2001; Harris et al.,
2001). Consistent with this, we found that M1 self-
association in solution was driven primarily by the M
domain, with a weaker contribution from the N-terminal
domain. Further supporting the importance of the M
domain in M1 oligomerization, Baudin et al. (2001) found
that mutations in helix 6 resulted in reduced polymeriza-
tion of the protein. Crystallographic analyses have yet to
provide information on the disposition of the C-terminal
domain, and a model for M1 oligomerization in virions
proposed that it lies out of the plane of the N+M domain
ribbon towards the interior of the particle, making little
contribution to the lattice (Harris et al., 2001). However,
our data suggest that the C-terminal domain does partici-
pate in M1–M1 interactions via the M domain. This is
perhaps consistent with the results of tritium-bombard-
ment experiments indicating that the C-terminal domain is
not buried in the interior of the virus particle (Shishkov
et al., 1999). If one accepts the plausible hypothesis that M1
amino acid sequence polymorphisms control virion shape
through subtle differences in packing, then our results are
also consistent with experiments mapping the filamentous
virion phenotype to sequences in the N, M and C domains
(Bourmakina & Garcia-Sastre, 2003; Elleman & Barclay,
2004; Burleigh et al., 2005).
Fig. 8. Incorporation of GFP–M1 polypeptides into filamentous
viral particles. Cells were transfected with plasmids expressing the
indicated GFP-fusion proteins and superinfected with PR8/MUd
virus. At 12 h post-infection, cells were fixed and the cell surface
was stained with anti-PR8 serum (in red) and imaged for red and
green fluorescence. The images shown are projections (made
using Leica TCS-SP software) of merged confocal stacks taken
across the cells at approximately 0.5 mm intervals in the xy plane
(upper panels) and approximately 0.8 mm intervals in the xz plane
(lower panels). Post-capture processing to allow daylight visuali-
zation of the images was performed by using Adobe Photoshop.
Bars, 10 mm.
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NP and M1 itself, only the full-length protein was recruited
into filamentous virions, raising the possibility that the
N- and C-terminal domains of M1 are important for
interaction(s) with other cellular and/or viral substrates
necessary for incorporation into virions. We hypothesize
that, in the absence of this/these interaction(s), fragments
of M1 containing the middle domain that are able to
self-associate and bind NP are nevertheless outcompeted
by authentic M1 for assembly into the budding virion.
Candidate viral factors include the cytoplasmic tails of
HA, NA (Enami & Enami, 1996; Jin et al., 1997) and M2
(Iwatsuki-Horimoto et al., 2006; McCown & Pekosz,
2006). Cellular candidates include membranes, as well as a
number of M1-interacting proteins of possible significance
to viral replication (Reinhardt & Wolff, 2000; Watanabe
et al., 2006).
The data presented here further demonstrate the multi-
functional role of the middle domain of M1. In addition to
its involvement in NP–RNP and –M1 interactions, pre-
vious studies have shown that the
101RKLKR
105 sequence
located in this domain mediates binding to RNA (Elster
et al., 1997), acts as a nuclear-localization signal (Ye et al.,
1995), interacts with nucleosomes (Garcia-Robles et al.,
2005), recruits NEP to enable RNP nuclear export (Akarsu
et al., 2003) and is involved in virus assembly (Burleigh
et al., 2005). Coordination of these different and possibly
competing functions during the influenza A virus life cycle
is likely to be partly regulated by M1’s late temporal expres-
sion and its differential localization, in both the nucleus
and the cytoplasm (Bucher et al., 1989). Currently, the
stoichiometry of the NEP–M1–RNP interaction necessary
for nuclear export is unknown; however, it is likely to be
low (Rey & Nayak, 1992; Whittaker et al., 1995; Elton et al.,
2001, 2005). The stoichiometry of the M1–RNP inter-
action in virions is also unknown, but recent work regard-
ing possible interactions between RNPs during genome
packaging (Fujii et al., 2003; Noda et al., 2006), coupled
with imaging of virus particles suggesting only limited
regions of contact between the matrix layer and RNPs
(Harris et al., 2006), raises the possibility that this too is far
lower than 1:1. Thus, oligomerized M1 may be able to
mediate more than one function simultaneously by form-
ing a meshwork in which individual monomers have non-
equivalent functions. Indeed, such a suggestion has already
been proposed to account for the ability of M1–NEP com-
plexes to co-sediment with histones, even though both
NEP and histones bind to the same region of the middle
domain (Garcia-Robles et al., 2005). Consistent with this
model, we found that excess NP does not compete with
WT M1 for binding to the middle domain of M1 (Fig. 6).
However, the relationship between heterodimerization of
NP and M1 and homopolymeric self-association is likely to
be complex, with potentially negative effects resulting from
competition for overlapping binding sites and positive
effects resulting from polymeric increases in avidity. We
suspect that these factors underlie the fact that titration of
M1 sub-fragments (which can self-associate, but perhaps
not polymerize) leads to a plateau in NP-binding activity,
whilst higher amounts of the full-length M1 fusion protein
display a lower binding capacity (Fig. 2b). Further com-
petition studies elucidating the hierarchy of M1 inter-
actions may reveal how M1 mediates its multiple roles.
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